Moffitt McKinley Outpatient Center — Tampa, Florida

Moffitt McKinley Outpatient Center is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Moffitt McKinley Outpatient Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors Harboring a BRAF V600 Mutation, Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma.

Sponsors: Pfizer, Replimune Inc., Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt McKinley Outpatient Center?

Moffitt McKinley Outpatient Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt McKinley Outpatient Center conducted?

Moffitt McKinley Outpatient Center has 3 clinical trials on record, with 1 currently active. Their work covers Solid Tumors Harboring a BRAF V600 Mutation, Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma.

Is Moffitt McKinley Outpatient Center accredited by Crixeo Health?

Moffitt McKinley Outpatient Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt McKinley Outpatient Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.